Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00675714 · ClinicalTrials.gov registry record · Phase 2
Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation
A Phase 2 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1,126
- Enrollment target
NCT00675714 is a Phase 2 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 1,126 participants.
The verdict
NCT00675714, a Phase 2 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1,126 participants
- Enrollment target
Study Summary
The purpose of the program is to study and characterize the outcome of burn injury with particular attention to improving the rehabilitation of burn survivors, including children. Various agents are assessed for effectiveness on long term burn outcome, such as growth hormone, oxandrolone, propranolol,ketoconazole, inhospital exercise and home exercise.
Interventions
- DRUG Ketoconazole
- DRUG Humatrope
- PROCEDURE Stable Isotope Infusion Study
- PROCEDURE Collection of blood and tissues
- PROCEDURE Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,126 participants |
| Start Date | 2004-01 |
| Est. Completion | 2019-07-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00675714
The ClinicalTrials.gov registry entry for NCT00675714 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1,126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Ketoconazole is the first listed.
NCT00675714 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00675714 about?
NCT00675714 is a clinical study titled "Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation". The purpose of the program is to study and characterize the outcome of burn injury with particular attention to improving the rehabilitation of burn survivors, including children. Various agents are assessed for effectiveness on long term burn outcome, such as growth hormone, oxandrolone, propranolo...
What is the current status of trial NCT00675714?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1,126 participants. The study started on 2004-01. Estimated completion is 2019-07-15.
What interventions are being tested in trial NCT00675714?
The interventions under investigation include: Ketoconazole (DRUG), Humatrope (DRUG), Stable Isotope Infusion Study (PROCEDURE), Collection of blood and tissues (PROCEDURE), Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00675714?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.